---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-047490"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T05:08:40.719368+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NYSE commences delisting of BiomX warrants (PHGE.WS) due to low price; common stock unaffected

## Summary
- On June 2, 2023, NYSE notified BiomX of delisting proceedings for warrants PHGE.WS under Section 1001.
- Warrant trading suspended immediately; low trading price cited as the sole reason.
- Common stock (PHGE) and units (PHGE.U) remain listed and trade normally on NYSE American.

## SEC filing metadata
- accession: 0001213900-23-047490
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390023047490/0001213900-23-047490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390023047490/ea180001-8k_biomxinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-047490
- JSON: https://secwatch.observer/filing/0001213900-23-047490.json
- Plain text: https://secwatch.observer/filing/0001213900-23-047490.txt

## Key facts
- Listing & Compliance Notices
  BiomX Inc. received a nyse_american delisting notice notice regarding other (rules 1001).
  - Exchange: nyse american
  - Notice: delisting notice
  - Rules: 1001
  source text: y’s common stock or units. Trading in the Company’s common stock (ticker symbol PHGE) and units (ticker symbol PHGE.U), will continue on the NYSE American. The NYSE justified its determination to commence proceedings to delist the Warrants because they are no longer suitable for listing pursuant to Section 1001 of the NYSE American Company due to the low trading price of the Warrants. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOMX INC. June 8
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390023047490/0001213900-23-047490-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.